Pulmonary Disease, Chronic Obstructive research hub
7 indexed studies · 5 currently recruiting
- recruiting
The London COPD Exacerbation Cohort
This study in London looks at people with an ongoing lung condition called COPD to understand why some have more flare-ups than others. We want to find out what makes these flare-ups happen and how they affect a person's health over time.
United Kingdom - recruitingPHASE3
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
This study is testing a new medicine, depemokimab, for adults aged 40-80 with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) and a specific type of inflammation. It aims to see if depemokimab improves symptoms and is safe when added to their usual inhaler treatment.
United States · Argentina · Australia - active not recruiting
Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting
This study looks at how a specific inhaler (Budesonide/Glycopyrronium/Formoterol, or BGF) works for people with a lung condition called COPD in real clinics. It uses information from different ongoing studies to learn more about this treatment.
Canada · Germany · Greece - recruitingPHASE1
A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Two GSK3862995B Formulations in Healthy Participants
This study is testing a new medicine called GSK3862995B. We want to see how the body uses two different versions of this medicine and check if they are safe for healthy adults. It's an early-stage study to understand the medicine better.
United Kingdom - recruitingPHASE3
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
This study is testing a new medicine, depemokimab, for people with moderate to severe COPD that involves a specific type of inflammation. We want to see if starting this medicine early helps improve their breathing and reduce flare-ups.
United States · Australia · Bulgaria - active not recruitingPHASE1
A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
This study is testing a new medicine, GSK3862995B, for safety in healthy people and those with Chronic Obstructive Pulmonary Disease (COPD). It aims to see how well people tolerate the medicine and if it causes any side effects, starting with small doses.
United States · Germany · United Kingdom - not yet recruitingPHASE2
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
This study is looking at a new medicine called Brenipatide for people with moderate to severe COPD, a lung condition. We want to see if different doses are safe and help improve symptoms, compared to a dummy medicine. The study will last about one year.
United States · Argentina · Austria